Investment
Features
FeesSafety
Academy
More
Pluang+

Compare AbCellera Biologics Inc (ABCL) vs ARK Next Generation Internet ETF (ARKW) Price & Performance

AbCellera Biologics IncTrade
ARK Next Generation Internet ETFTrade

Price performance (Past 24H)

Key statistics

AbCellera Biologics Inc vs ARK Next Generation Internet ETF — how do they compare? AbCellera Biologics Inc trades at $10.28 (market cap $2.99B), while ARK Next Generation Internet ETF trades at $150.74. The key difference: AbCellera Biologics Inc is trading nearer its 52-week high, ARK Next Generation Internet ETF nearer its low. Which is the better fit depends on your goals.

ABCLARKW
Market Cap
$2.99B
Sector
HealthSector/Thematic
52-Week High
$9.76$182.20
52-Week Low
$2.78$114.45
Enterprise Value
$2.58B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

AbCellera Biologics Inc

ABCL's stock rose 7.07% to $10.00, buoyed by positive Phase 2 trial results for its menopause drug ABCL635, which demonstrated an 83% reduction in hot flashes (Business Wire, August 10, 2026). Despite negative profitability margins and cash burn, technical indicators show a bullish trend with strong moving average support. The company maintains a solid balance sheet with $625.61 million in cash and low debt, though revenue declined from $485 million in 2022 to $75 million in 2025.

The outlook hinges on clinical success and monetization of ABCL635, with a consensus price target of $15.50 implying 55% upside. Key risks include prolonged cash burn, drug development setbacks, and competitive pressures. Analyst sentiment is overwhelmingly bullish (91.67% buy ratings), but investors must weigh high valuation multiples against unproven commercial traction.

ARK Next Generation Internet ETF

ARKW trades at $151.00, up 0.95% with bullish technical signals from moving averages. The ETF faces near-term headwinds from elevated AI infrastructure spending but maintains long-term growth potential through holdings like AMD and TSLA. Technical indicators show mixed signals with RSI suggesting potential overbought conditions while ADX indicates strong trend strength.

The ETF's outlook balances near-term capital expenditure pressures against long-term AI growth opportunities. Key risks include market skepticism toward tech valuations and sector volatility, while institutional interest in AI exposure provides support. Current positioning near resistance at $152 suggests potential for consolidation before next directional move.

Returns comparison

Trailing returns across standard periods

About AbCellera Biologics Inc

AbCellera Biologics Inc is a biotechnology company. It develops antibodies to treat infectious diseases and various other types of diseases. The company's AI-powered technology sources, searches, decodes and analyzes antibody responses to engineer new antibody drug candidates for its partners.

Read more on ABCL

About ARK Next Generation Internet ETF

ARKW is an actively managed ETF that invests in next-generation internet technologies. It focuses on cloud computing, AI, e-commerce, and blockchain innovation, with key holdings like Tesla, Advanced Micro Devices, and Roku.

Read more on ARKW